Cargando…
Discovery of Novel N-Substituted Prolinamido Indazoles as Potent Rho Kinase Inhibitors and Vasorelaxation Agents
Inhibitors of Rho kinase (ROCK) have potential therapeutic applicability in a wide range of diseases, such as hypertension, stroke, asthma and glaucoma. In a previous article, we described the lead discovery of DL0805, a new ROCK I inhibitor, showing potent inhibitory activity (IC(50) 6.7 μM). Herei...
Autores principales: | Yao, Yangyang, Li, Renze, Liu, Xiaoyu, Yang, Feilong, Yang, Ying, Li, Xiaoyu, Shi, Xiang, Yuan, Tianyi, Fang, Lianhua, Du, Guanhua, Jiao, Xiaozhen, Xie, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151428/ https://www.ncbi.nlm.nih.gov/pubmed/29048389 http://dx.doi.org/10.3390/molecules22101766 |
Ejemplares similares
-
The Vasorelaxant Mechanisms of a Rho Kinase Inhibitor DL0805 in Rat Thoracic Aorta
por: Gong, Lili, et al.
Publicado: (2012) -
New pyridine and chromene scaffolds as potent vasorelaxant and anticancer agents
por: Dawood, Dina H., et al.
Publicado: (2021) -
Metal-free regioselective mono- and poly-halogenation of 2-substituted indazoles
por: Zhang, Changjun, et al.
Publicado: (2023) -
Design, Synthesis and Biological Evaluation of 6-(2,6-Dichloro-3,5-dimethoxyphenyl)-4-substituted-1H-indazoles as Potent Fibroblast Growth Factor Receptor Inhibitors
por: Zhang, Zhen, et al.
Publicado: (2016) -
Discovery of Orexant and Anorexant Agents with Indazole Scaffold Endowed with Peripheral Antiedema Activity
por: Dimmito, Marilisa P., et al.
Publicado: (2019)